21st May 2018 15:35
PRESS RELEASE
Annual Report and Notice of AGM
London, UK - 21 May 2018: Ergomed plc (LSE: ERGO) ('Ergomed' or the 'Company'), a company focused on providing specialised services to the pharmaceutical industry, announces that it will host its Annual General Meeting at the offices of Covington & Burling LLP, 265 Strand, London WC2R 1BH at 9.30am on Tuesday 12th June 2018.
The Annual Report and Accounts for the year ended 31 December 2017, Notice of AGM and Proxy have been mailed to shareholders today, Monday 21st May 2018. The Annual Report and Accounts will be available on the Company's website: www.ergomedplc.com.
- ENDS -
Enquiries:
Ergomed plc | Tel: +44 (0) 1483 503 205 |
Stephen Stamp (Chief Executive Officer) | |
Numis Securities Limited | Tel: +44 (0) 20 7260 1000 |
Michael Meade / Freddie Barnfield (Nominated Adviser) | |
James Black (Joint Broker) | |
N+1 Singer (Joint Broker) | Tel: +44 (0) 20 7496 3000 |
Alex Price | |
Consilium Strategic Communications - for UK enquiries | Tel: +44 (0) 20 3709 5700 |
Chris Gardner / Mary-Jane Elliott Ivar Milligan / Philippa Gardner | |
MC Services - for Continental European enquiries | Tel: +49 211 5292 5222 |
Anne Hennecke |
About Ergomed
Ergomed provides specialist services to the pharmaceutical industry and develops drugs both wholly-owned and through partnerships. Ergomed's fast-growing, profitable service offering spans all phases of clinical development and post-approval pharmacovigilance and medical information. Drawing on more than 20 years of expertise in drug development, Ergomed has established a portfolio of drug development partnerships and programmes, including wholly-owned proprietary products for the treatment of surgical bleeding. For further information, visit: http://ergomedplc.com.
Related Shares:
ERGO.L